A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal
- 1 October 1997
- Vol. 15 (15), 1606-1612
- https://doi.org/10.1016/s0264-410x(97)00100-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Practical Experiences in Obtaining Informed Consent for a Vaccine Trial in Rural AfricaNew England Journal of Medicine, 1997
- Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infantsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis VaccineNew England Journal of Medicine, 1996
- A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against PertussisNew England Journal of Medicine, 1996
- Acellular Pertussis Vaccines for InfantsNew England Journal of Medicine, 1996
- Efficacy of acellular pertussis vaccine in early childhood after household exposurePublished by American Medical Association (AMA) ,1996
- A Placebo-Controlled Trial of a Pertussis-Toxoid VaccineNew England Journal of Medicine, 1995
- Relative efficacy of two acellular pertussis vaccines during three years of passive surveillanceVaccine, 1992
- Reflections on the Efficacy of Pertussis VaccinesClinical Infectious Diseases, 1987